» Articles » PMID: 33470749

Thalamic Neurometabolite Alterations in Patients with Knee Osteoarthritis Before and After Total Knee Replacement

Abstract

The weak association between disability levels and "peripheral" (ie, knee) findings suggests that central nervous system alterations may contribute to the pathophysiology of knee osteoarthritis (KOA). Here, we evaluated brain metabolite alterations in patients with KOA, before and after total knee arthroplasty (TKA), using 1H-magnetic resonance spectroscopy (MRS). Thirty-four presurgical patients with KOA and 13 healthy controls were scanned using a PRESS sequence (TE = 30 ms, TR = 1.7 seconds, voxel size = 15 × 15 × 15 mm). In addition, 13 patients were rescanned 4.1 ± 1.6 (mean ± SD) weeks post-TKA. When using creatine (Cr)-normalized levels, presurgical KOA patients demonstrated lower N-acetylaspartate (NAA) (P < 0.001), higher myoinositol (mIns) (P < 0.001), and lower Choline (Cho) (P < 0.05) than healthy controls. The mIns levels were positively correlated with pain severity scores (r = 0.37, P < 0.05). These effects reached statistical significance also using water-referenced concentrations, except for the Cho group differences (P ≥ 0.067). Post-TKA patients demonstrated an increase in NAA (P < 0.01), which returned to the levels of healthy controls (P > 0.05), irrespective of metric. In addition, patients demonstrated postsurgical increases in Cr-normalized (P < 0.001), but not water-referenced mIns, which were proportional to the NAA/Cr increases (r = 0.61, P < 0.05). Because mIns is commonly regarded as a glial marker, our results are suggestive of a possible dual role for neuroinflammation in KOA pain and post-TKA recovery. Moreover, the apparent postsurgical normalization of NAA, a putative marker of neuronal integrity, might implicate mitochondrial dysfunction, rather than neurodegenerative processes, as a plausible pathophysiological mechanism in KOA. More broadly, our results add to a growing body of literature suggesting that some pain-related brain alterations can be reversed after peripheral surgical treatment.

Citing Articles

A novel blood-free analytical framework for the quantification of neuroinflammatory load from TSPO PET Imaging.

Maccioni L, Brusaferri L, Barzon L, Schubert J, Nettis M, Cousins O Res Sq. 2025; .

PMID: 39975931 PMC: 11838776. DOI: 10.21203/rs.3.rs-5924801/v1.


Identification of Key Factors in Cartilage Tissue During the Progression of Osteoarthritis Using a Non-targeted Metabolomics Strategy.

Sun S, Chen M, Zhang T, Wang Y, Shen W, Zhang T Phenomics. 2024; 4(3):227-233.

PMID: 39398425 PMC: 11466919. DOI: 10.1007/s43657-023-00123-z.


Chronic neuropathic pain components in whiplash-associated disorders correlate with metabolite concentrations in the anterior cingulate and dorsolateral prefrontal cortex: a consensus-driven MRS re-examination.

Pinilla-Fernandez I, Rios-Leon M, Deelchand D, Garrido L, Torres-Llacsa M, Garcia-Garcia F Front Med (Lausanne). 2024; 11:1404939.

PMID: 39156690 PMC: 11328873. DOI: 10.3389/fmed.2024.1404939.


A blood-free modeling approach for the quantification of the blood-to-brain tracer exchange in TSPO PET imaging.

Maccioni L, Michelle C, Brusaferri L, Silvestri E, Bertoldo A, Schubert J Front Neurosci. 2024; 18:1395769.

PMID: 39104610 PMC: 11299498. DOI: 10.3389/fnins.2024.1395769.


Neuroimmune activation and increased brain aging in chronic pain patients after the COVID-19 pandemic onset.

Brusaferri L, Alshelh Z, Schnieders J, Sandstrom A, Mohammadian M, Morrissey E Brain Behav Immun. 2023; 116:259-266.

PMID: 38081435 PMC: 10872439. DOI: 10.1016/j.bbi.2023.12.016.


References
1.
Clark J . N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci. 1998; 20(4-5):271-6. DOI: 10.1159/000017321. View

2.
Bellamy N, BUCHANAN W, Goldsmith C, Campbell J, Stitt L . Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15(12):1833-40. View

3.
Gwilym S, Filippini N, Douaud G, Carr A, Tracey I . Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study. Arthritis Rheum. 2010; 62(10):2930-40. DOI: 10.1002/art.27585. View

4.
Watkins L, Hutchinson M, Ledeboer A, Wieseler-Frank J, Milligan E, Maier S . Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun. 2006; 21(2):131-46. PMC: 1857294. DOI: 10.1016/j.bbi.2006.10.011. View

5.
Bennett G, Doyle T, Salvemini D . Mitotoxicity in distal symmetrical sensory peripheral neuropathies. Nat Rev Neurol. 2014; 10(6):326-36. PMC: 4870000. DOI: 10.1038/nrneurol.2014.77. View